Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146


Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.

Kolpen M, Lerche CJ, Kragh KN, Sams T, Koren K, Jensen AS, Line L, Bjarnsholt T, Ciofu O, Moser C, Kühl M, Høiby N, Jensen PØ.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01024-17. doi: 10.1128/AAC.01024-17. Print 2017 Nov.


Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Møller ME, Alanin MC, Grønhøj C, Aanæs K, Høiby N, von Buchwald C.

Am J Rhinol Allergy. 2017 Sep 1;31(5):293-298. doi: 10.2500/ajra.2017.31.4461.


Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.

Trøstrup H, Lerche CJ, Christophersen L, Jensen PØ, Høiby N, Moser C.

Int J Mol Sci. 2017 Jun 26;18(7). pii: E1359. doi: 10.3390/ijms18071359.


Bacterial evolution in PCD and CF patients follows the same mutational steps.

Sommer LM, Alanin MC, Marvig RL, Nielsen KG, Høiby N, von Buchwald C, Molin S, Johansen HK.

Sci Rep. 2016 Jun 28;6:28732. doi: 10.1038/srep28732.


Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model.

Cao B, Christophersen L, Kolpen M, Jensen PØ, Sneppen K, Høiby N, Moser C, Sams T.

PLoS One. 2016 Apr 21;11(4):e0153616. doi: 10.1371/journal.pone.0153616. eCollection 2016.


Genome Sequence of Pseudomonas aeruginosa Strain DK1-NH57388A, a Stable Mucoid Cystic Fibrosis Isolate.

Norman A, Ciofu O, Amador CI, Høiby N, Jelsbak L.

Genome Announc. 2016 Feb 25;4(1). pii: e00008-16. doi: 10.1128/genomeA.00008-16.


Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.

Thomsen K, Christophersen L, Jensen PØ, Bjarnsholt T, Moser C, Høiby N.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1690-9. doi: 10.1080/21645515.2016.1145848. Epub 2016 Feb 22.


OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model.

Hengzhuang W, Song Z, Ciofu O, Onsøyen E, Rye PD, Høiby N.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2620-6. doi: 10.1128/AAC.01721-15. Print 2016 May.


The phagocytic fitness of leucopatches may impact the healing of chronic wounds.

Thomsen K, Trøstrup H, Christophersen L, Lundquist R, Høiby N, Moser C.

Clin Exp Immunol. 2016 Jun;184(3):368-77. doi: 10.1111/cei.12773. Epub 2016 Mar 23.


Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis.

Qvist T, Taylor-Robinson D, Waldmann E, Olesen HV, Hansen CR, Mathiesen IH, Høiby N, Katzenstein TL, Smyth RL, Diggle PJ, Pressler T.

J Cyst Fibros. 2016 May;15(3):380-5. doi: 10.1016/j.jcf.2015.09.007. Epub 2015 Oct 9.


The LapG protein plays a role in Pseudomonas aeruginosa biofilm formation by controlling the presence of the CdrA adhesin on the cell surface.

Rybtke M, Berthelsen J, Yang L, Høiby N, Givskov M, Tolker-Nielsen T.

Microbiologyopen. 2015 Dec;4(6):917-30. doi: 10.1002/mbo3.301. Epub 2015 Oct 12.


Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.

Kolpen M, Appeldorff CF, Brandt S, Mousavi N, Kragh KN, Aydogan S, Uppal HA, Bjarnsholt T, Ciofu O, Høiby N, Jensen PØ.

Pathog Dis. 2016 Feb;74(1):ftv086. doi: 10.1093/femspd/ftv086. Epub 2015 Oct 12.


Antibiofilm Properties of Acetic Acid.

Bjarnsholt T, Alhede M, Jensen PØ, Nielsen AK, Johansen HK, Homøe P, Høiby N, Givskov M, Kirketerp-Møller K.

Adv Wound Care (New Rochelle). 2015 Jul 1;4(7):363-372.


Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Paulsson M, Singh B, Al-Jubair T, Su YC, Høiby N, Riesbeck K.

J Cyst Fibros. 2015 Sep;14(5):600-7. doi: 10.1016/j.jcf.2015.05.005. Epub 2015 Jun 3.


Anti-Pseudomonas aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils.

Thomsen K, Christophersen L, Bjarnsholt T, Jensen PØ, Moser C, Høiby N.

Infect Immun. 2015 Jul;83(7):2686-93. doi: 10.1128/IAI.02970-14. Epub 2015 Apr 20.


Strategies for combating bacterial biofilm infections.

Wu H, Moser C, Wang HZ, Høiby N, Song ZJ.

Int J Oral Sci. 2015 Mar 23;7(1):1-7. doi: 10.1038/ijos.2014.65. Review.


Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.

Qvist T, Johansen IS, Pressler T, Høiby N, Andersen AB, Katzenstein TL, Bjerrum S.

BMC Infect Dis. 2014 Dec 4;14:655. doi: 10.1186/s12879-014-0655-4.


Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum.

Line L, Alhede M, Kolpen M, Kühl M, Ciofu O, Bjarnsholt T, Moser C, Toyofuku M, Nomura N, Høiby N, Jensen PØ.

Front Microbiol. 2014 Oct 24;5:554. doi: 10.3389/fmicb.2014.00554. eCollection 2014.


Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization.

Hansen N, Rasmussen AK, Fiandaca MJ, Kragh KN, Bjarnsholt T, Høiby N, Stender H, Guardabassi L.

New Microbes New Infect. 2014 May;2(3):79-81. doi: 10.1002/nmi2.38. Epub 2014 Mar 25.


Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa.

Markussen T, Marvig RL, Gómez-Lozano M, Aanæs K, Burleigh AE, Høiby N, Johansen HK, Molin S, Jelsbak L.

MBio. 2014 Sep 16;5(5):e01592-14. doi: 10.1128/mBio.01592-14.

Supplemental Content

Loading ...
Support Center